| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 11/06/2013 | CN102245174B Synergistic effects between sphingosine-1-phosphate receptor antagonists and antimicrotubule agents |
| 11/06/2013 | CN102241604B Amino acid modified curcumin, synthesis method thereof, and application thereof |
| 11/06/2013 | CN102241593B Protoilludance norsesquiterpenoid esters and uses thereof |
| 11/06/2013 | CN102234671B Method for extracting polysaccharide from longan pulp |
| 11/06/2013 | CN102225919B Curcumin analogue and preparation method thereof as well as application thereof in preparation of Alzheimer disease resisting medicament |
| 11/06/2013 | CN102219670B Linear chain polyketone compounds and application thereof |
| 11/06/2013 | CN102212093B Flavonoid glycoside compounds, method for preparing same and application |
| 11/06/2013 | CN102212001B Compound salvianolic acid F methyl ester and preparation method thereof |
| 11/06/2013 | CN102198150B Antitumor drug with double active components and application thereof |
| 11/06/2013 | CN102196810B Pharmaceutical composition improved in absorption through intestinal tract |
| 11/06/2013 | CN102188422B Compound florfenicol injection and preparation method and application thereof |
| 11/06/2013 | CN102186463B Nutritional composition to promote healthy development and growth |
| 11/06/2013 | CN102171221B Novel fused aminodihydrothiazine derivative |
| 11/06/2013 | CN102145123B Speckle removing medicine |
| 11/06/2013 | CN102137853B Glucosyltransferase inhibitor comprising epigallocatechin gallate polymer as active ingredient |
| 11/06/2013 | CN102127050B Bisbibenzyl Mannich base derivative, preparation method and application thereof |
| 11/06/2013 | CN102125545B Application of o-quinone structure-contained compounds in preparing tumor resistant medicament |
| 11/06/2013 | CN102099336B Novel phenylamino isonicotinamide compounds |
| 11/06/2013 | CN102085193B Tibolone orally disintegrating tablets and method for preparing same |
| 11/06/2013 | CN102083413B Method and composition for treating ocular hypertension and glaucoma |
| 11/06/2013 | CN102066358B Piperidine derivatives as CGRP receptor antagonists |
| 11/06/2013 | CN102056923B New co-crystal compound of rivaroxaban and malonic acid |
| 11/06/2013 | CN102014941B Activation of innate and adaptive immune responses by a ginseng extract |
| 11/06/2013 | CN102006869B Treatment of energy utilization disease |
| 11/06/2013 | CN102000043B Flurbiprofen salt transdermal patch and preparation method thereof |
| 11/06/2013 | CN101984961B Furanodiene-containing medicinal composition, technology for preparing preparation thereof and medicinal use thereof |
| 11/06/2013 | CN101979397B HCV nucleoside inhibitor |
| 11/06/2013 | CN101965337B Novel 1-benzil-3-hydroxymethylindazole derivatives and use thereof in the treatment of diseases based on the expression of mcp-1, cx3cr1 and p40 |
| 11/06/2013 | CN101918417B Pyridine derivative substituted with heterocycle and phosphonoxymethyl group and antifungal agent containing the same |
| 11/06/2013 | CN101918376B 1, 2, 3-triazole derivatives for use as stearoyl-coa desaturase inhibitors |
| 11/06/2013 | CN101912394B Medicinal composition for treating coagulopathy haemorrhage and application thereof |
| 11/06/2013 | CN101909651B External preparation composition comprising fatty acid-based ionic liquid as active ingredient |
| 11/06/2013 | CN101903385B 4-aminopyrimidine derivatives as histamine H4 receptor antagonists |
| 11/06/2013 | CN101899006B 2,4,5-trisubstituted imidazoles and their use as anti-microbial agents |
| 11/06/2013 | CN101890012B Paracetamol,loratadine and pseudoephedrine sulfate sustained release tablet and preparation method thereof |
| 11/06/2013 | CN101835772B Novel imidazole derivatives |
| 11/06/2013 | CN101815790B Method for production of carotenoid |
| 11/06/2013 | CN101801970B Adenosine derivatives, method for the synthesis thereof, and the pharmaceutical compositions for the prevention and treatment of the inflammatory diseases containing the same as an active ingredient |
| 11/06/2013 | CN101786952B Anthraquinone compound and preparation method and medical application of lysine salt thereof |
| 11/06/2013 | CN101778574B Abrasion-resistant free-flowing glycocyamine-containing mouldings and methods for their production |
| 11/06/2013 | CN101772490B Trazodone and trazodone hydrochloride in purified form |
| 11/06/2013 | CN101744905B Applications of Chinese medicinal composition in preparation of medicament for treating pulmonary heart disease |
| 11/06/2013 | CN101732306B New application of natural product amentoflavone in treating cancers |
| 11/06/2013 | CN101687847B N5-(2-ethoxyethyl)-N3-(2-pyridinyl) -3,5-piperidinedicarboxamide derivatives for use as renin inhibitors |
| 11/06/2013 | CN101679425B 6-(pyrrolopyridinyl)-pyrimidine-2-yl-amine and its uses in treating cancer and AIDS |
| 11/06/2013 | CN101659654B 2-Methylpiperazine fluoroquinolone compound and preparation method and application thereof |
| 11/06/2013 | CN101652143B A composition for selective serotonin reuptake inhibition and process thereof |
| 11/06/2013 | CN101648004B Medicinal composition for treating eye diseases and application thereof |
| 11/06/2013 | CN101641346B Pyridine and pyrimidine derivatives as mglur2 antagonists |
| 11/06/2013 | CN101633609B New compound separated from leaves of rubus corchorifolius and preparation method and use thereof |
| 11/06/2013 | CN101632833B Prostatic cancer related gene and application thereof |
| 11/06/2013 | CN101611005B Substituted acetophenones useful as PDE4 inhibitors |
| 11/06/2013 | CN101534904B BCL inhibitors treating platelet excess |
| 11/06/2013 | CN101484588B Compositions and methods for inhibiting expression of the pcsk9 gene |
| 11/06/2013 | CN101475506B Antineoplastic use of higher fatty acid derivative novel compound |
| 11/06/2013 | CN101466736B Therapy targeting cathepsin S |
| 11/06/2013 | CN101460059B Compound for antimicrobial therapy for bacterial infections and its pharmaceutical uses |
| 11/06/2013 | CN101448822B Substituted pyrazolopyrimidines |
| 11/06/2013 | CN101365703B Heteroalkyl linked pyrimidine derivatives |
| 11/06/2013 | CN101361723B Improved pharmaceutical compositions |
| 11/06/2013 | CN101304987B Aminophenylsulfonamide derivatives as HIV protease inhibitor |
| 11/06/2013 | CN101302515B Human antibodies that bind human TNF(alpha) |
| 11/06/2013 | CN101287724B Solid salt forms of a pyrrole substituted 2-indolinone |
| 11/06/2013 | CN101273042B Macrocyclic inhibitors of hepatitis C virus |
| 11/06/2013 | CN101267815B Metal-beta-lactamase inhibitor |
| 11/06/2013 | CN101189337B Ghrelin binding nucleic acids |
| 11/06/2013 | CN101134038B 缓释的口服给药组合物 The sustained-release composition for oral administration |
| 11/06/2013 | CN101076345B Medicine for preventing and curing human genital system disorder and method for manufacturing the same |
| 11/06/2013 | CN101073667B Enhancer for antibody to lymphocytic tumors |
| 11/06/2013 | CN101010302B Sigma receptor inhibitors |
| 11/06/2013 | CN101006052B Pyrrole derivatives as pharmaceutical agents |
| 11/05/2013 | USRE44578 Stable pharmaceutical compositions containing 7-substituted-3,5-dihydroxyheptanoic acids or 7-substituted-3,5-dihydroxyheptenoic acids |
| 11/05/2013 | US8575400 Therapeutic compounds |
| 11/05/2013 | US8575391 5-substituted-2-phenylamino benzamides as MEK inhibitors |
| 11/05/2013 | US8575376 Steroide anionic compounds, method of their production, usage and pharmaceutical preparation involving them |
| 11/05/2013 | US8575368 Proanthocyanidin of cashew apple, composition containing proanthocyanidin, and application thereof |
| 11/05/2013 | US8575364 Modulators of serotonin receptor |
| 11/05/2013 | US8575363 Amino-pyrrolidine-azetidine diamides as monoacylglycerol lipase inhibitors |
| 11/05/2013 | US8575361 Tetrahydronaphthalene derivatives |
| 11/05/2013 | US8575360 Derivatives of 6,7-dihydro-5H-imidazo[1,2-a]imidazole-3-carboxylic acid amides |
| 11/05/2013 | US8575357 Substituted (thiazolyl-carbonyl)imidazolidinones and use thereof |
| 11/05/2013 | US8575353 Compounds for the treatment of addiction |
| 11/05/2013 | US8575352 Benzyl sulfonamide derivatives useful as MOGAT-2 inhibitors |
| 11/05/2013 | US8575351 Active metabolite of a thrombin receptor antagonist |
| 11/05/2013 | US8575347 Muscarinic acetylcholine receptor antagonists |
| 11/05/2013 | US8575342 HIV inhibiting 5-heterocyclyl pyrimidines |
| 11/05/2013 | US8575340 Purine derivatives and their pharmaceutical uses |
| 11/05/2013 | US8575338 Pyrimidine, pyridine and triazine derivatives as maxi-K channel openers |
| 11/05/2013 | US8575333 Halogenated alkyl di- and trisaccharides, pharmaceutical formulations, diagnostic kits and methods of treatment |
| 11/05/2013 | US8575224 Procedure for obtaining an aqueous dispersion of alcohols and acids from jojoba oil, processes for obtaining self-emulsified jojoba oil, aqueous dispersions and emulsions of jojoba oil in the same and pharmaceutical or cosmetic compositions comprising the same |
| 11/05/2013 | US8575222 Use of nitrooxyderivatives of drug for the treatment of muscular dystrophies |
| 11/05/2013 | US8575221 Derivatives of dimethylcurcumin |
| 11/05/2013 | US8575219 Compounds for the treatment of psychiatric or substance abuse disorders |
| 11/05/2013 | US8575217 Anti-inflammatory and antioxidant conjugates useful for treating metabolic disorders |
| 11/05/2013 | US8575215 Treatment of neurodegenerative and cardiovascular disorders |
| 11/05/2013 | US8575214 MGlu 2/3 agonists |
| 11/05/2013 | US8575213 Pyrethrinoid-type esters as pesticides |
| 11/05/2013 | US8575212 Organically chelated mineral compositions and methods thereof |
| 11/05/2013 | US8575211 Synergistic combination of analgesic compounds |
| 11/05/2013 | US8575210 Use of indole derivatives as NURR-1 activators for treating parkinson's disease |